The molecular basis of the inhibition of HTLV-2 retroviral replication by the MHC class II transactivator (ClITA)

被引：0
|
作者：
Tosi, G
Pilotti, E
Barbaro, ADL
Mortara, L
Casoli, C
Accolla, RS
机构：
[1] Univ Insubria, Dept Clin & Biol Sci, Varese, Italy
[2] Univ Parma, Dept Clin Med Nephrol & Prevent, I-43100 Parma, Italy
来源：
TISSUE ANTIGENS | 2005年 / 66卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
2
引用
收藏
页码：343 / 343
页数：1
相关论文
共 50 条
  • [21] ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity
    Cachat, Anne
    Alais, Sandrine
    Chevalier, Sebastien Alain
    Journo, Chloe
    Fusil, Floriane
    Dutartre, Helene
    Boniface, Adrien
    Ko, Nga Ling
    Gessain, Antoine
    Cosset, Francois-Loic
    Suspene, Rodolphe
    Vartanian, Jean-Pierre
    Mahieux, Renaud
    RETROVIROLOGY, 2014, 11
  • [22] The Smad3 protein is involved in TGF-β inhibition of class II transactivator and class II MHC expression
    Dong, YS
    Tang, LP
    Letterio, JJ
    Benveniste, EN
    JOURNAL OF IMMUNOLOGY, 2001, 167 (01): : 311 - 319
  • [23] Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (ClITA) type IV promoter
    Piskurich, Janet
    Chen, Han
    Gilbert, Carolyn
    Hudson, John
    Wright, Kenneth
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S239 - S239
  • [24] The Molecular and Cellular Basis of Tumor Rejection After Vaccination With Mammary Adenocarcinoma Cells Transduced With the MHC Class II Transactivator CIITA
    Lorenzo Mortara
    Paola Castellani
    Raffaella Meazza
    Giovanna Tosi
    Andrea De Lerma Barbaro
    Francesco A Procopio
    Luciano Zardi
    Silvano Ferrini
    Roberto S Accolla
    Retrovirology, 2
  • [25] The molecular and cellular basis of tumor rejection after vaccination with mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA
    Mortara, Lorenzo
    Castellani, Paola
    Meazza, Raffaella
    Tosi, Giovanna
    Barbaro, Andrea De Lerma
    Procopio, Francesco A.
    Zardi, Luciano
    Ferrini, Silvano
    Accolla, Roberto S.
    RETROVIROLOGY, 2005, 2 (Suppl 1)
  • [26] Reply to correspondence on "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction"
    Lee, Cho-Rong
    Park, Sung-Gyoo
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [27] A MOLECULAR-BASIS FOR MHC CLASS-II - ASSOCIATED AUTOIMMUNITY
    TODD, JA
    ACHAORBEA, H
    BELL, JI
    CHAO, N
    FRONEK, Z
    JACOB, CO
    MCDERMOTT, M
    SINHA, AA
    TIMMERMAN, L
    STEINMAN, L
    MCDEVITT, HO
    SCIENCE, 1988, 240 (4855) : 1003 - 1009
  • [28] Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA)
    Patarroyo, JC
    Stuve, O
    Piskurich, JF
    Hauser, SL
    Oksenberg, JR
    Zamvill, SS
    GENES AND IMMUNITY, 2002, 3 (01) : 34 - 37
  • [29] Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA)
    J C Patarroyo
    O Stuve
    J F Piskurich
    S L Hauser
    J R Oksenberg
    S S Zamvil
    Genes & Immunity, 2002, 3 : 34 - 37
  • [30] Human oncogenic retrovirus HTLV-1 replication is suppressed by the MHC class II transcriptional activator CIITA via an inhibitory action on the viral transactivator Tax-1
    Tosi, G.
    Forlani, G.
    Andresen, V.
    Turci, M.
    Bertazzoni, U.
    Franchini, G.
    Accolla, R.
    IMMUNOLOGY, 2012, 137 : 639 - 639
12345